BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2108 related articles for article (PubMed ID: 9066101)

  • 1. Antineutrophil nuclear antibodies (ANNA) in primary biliary cirrhosis: their prevalence and antigen specificity.
    Orth T; Gerken G; Meyer Zum Büschenfelde KH; Mayet WJ
    Z Gastroenterol; 1997 Feb; 35(2):113-21. PubMed ID: 9066101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic accuracy of atypical p-ANCA in autoimmune hepatitis using ROC- and multivariate regression analysis.
    Terjung B; Bogsch F; Klein R; Söhne J; Reichel C; Wasmuth JC; Beuers U; Sauerbruch T; Spengler U
    Eur J Med Res; 2004 Sep; 9(9):439-48. PubMed ID: 15546809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antineutrophil cytoplasmic antibody in patients with antinuclear antibody-positive chronic hepatitis C.
    Ohira H; Tojo J; Shinzawa J; Suzuki T; Miyata M; Nishimaki T; Kasukawa R
    Fukushima J Med Sci; 1998 Dec; 44(2):83-92. PubMed ID: 10091380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PML nuclear body component Sp140 is a novel autoantigen in primary biliary cirrhosis.
    Granito A; Yang WH; Muratori L; Lim MJ; Nakajima A; Ferri S; Pappas G; Quarneti C; Bianchi FB; Bloch DB; Muratori P
    Am J Gastroenterol; 2010 Jan; 105(1):125-31. PubMed ID: 19861957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseases.
    Mulder AH; Horst G; Haagsma EB; Limburg PC; Kleibeuker JH; Kallenberg CG
    Hepatology; 1993 Mar; 17(3):411-7. PubMed ID: 8444414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies to SS-A/Ro-52kD and centromere in autoimmune liver disease: a clue to diagnosis and prognosis of primary biliary cirrhosis.
    Granito A; Muratori P; Muratori L; Pappas G; Cassani F; Worthington J; Ferri S; Quarneti C; Cipriano V; de Molo C; Lenzi M; Chapman RW; Bianchi FB
    Aliment Pharmacol Ther; 2007 Sep; 26(6):831-8. PubMed ID: 17767467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence, kinetics, and therapeutic modulation of autoantibodies against Sp100 and promyelocytic leukemia protein in a large cohort of patients with primary biliary cirrhosis.
    Züchner D; Sternsdorf T; Szostecki C; Heathcote EJ; Cauch-Dudek K; Will H
    Hepatology; 1997 Nov; 26(5):1123-30. PubMed ID: 9362351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-neutrophil cytoplasmic antibodies in patients with chronic liver diseases: prevalence, antigen specificity and predictive value for diagnosis of autoimmune liver disease. Swedish Internal Medicine Liver Club (SILK).
    Lindgren S; Nilsson S; Nässberger L; Verbaan H; Wieslander J
    J Gastroenterol Hepatol; 2000 Apr; 15(4):437-42. PubMed ID: 10824890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Autoimmune hepatitis and overlap syndrome: diagnosis].
    Berg PA; Klein R
    Praxis (Bern 1994); 2002 Aug; 91(34):1339-46. PubMed ID: 12233264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antineutrophil cytoplasmic autoantibodies in patients with systemic lupus erythematosus recognize a novel 69 kDa target antigen of neutrophil granules.
    Chen M; Zhao MH; Zhang YK; Wang HY
    Nephrology (Carlton); 2005 Oct; 10(5):491-5. PubMed ID: 16221101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical significance of anti-centromere antibody and anti-CENP-B antibody in sera of patients with primary biliary cirrhosis].
    Onozuka Y; Shibata M; Yonezawa H; Terauti K; Miyachi K; Ueno Y
    Rinsho Byori; 1996 Sep; 44(9):877-82. PubMed ID: 8911074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occurrence of antineutrophil cytoplasmic and antineutrophil (peri)nuclear antibodies in rheumatoid arthritis.
    Bosch X; Llena J; Collado A; Font J; Mirapeix E; Ingelmo M; Muñoz-Gómez J; Urbano-Márquez A
    J Rheumatol; 1995 Nov; 22(11):2038-45. PubMed ID: 8596141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunological characteristics of primary biliary cirrhosis patients].
    Yan HP; Zhuang H; Liu YM; Feng X; Tan YF; Liu Y; Zhang X; Zhao CH
    Zhonghua Gan Zang Bing Za Zhi; 2005 Jan; 13(1):12-6. PubMed ID: 15670483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Detection of anti-nuclear antibodies in liver diseases by indirect immunofluorescence method and enzyme-linked immunosorbent assay].
    Koizumi H; Onozuka Y; Shibata M; Sano K; Oosima Y; Miyachi K; Ueno Y
    Rinsho Byori; 1999 Aug; 47(8):744-8. PubMed ID: 10511806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anti-Sp100 and anti-Gp210 in the diagnosis of primary biliary cirrhosis in patients with autoimmune cholangitis].
    Romero Gómez M; Wichmann I; Otero Fernández MA; Suárez García E; Grande L; Núñez J; Nevado Santos M; Castro Fernández M
    Gastroenterol Hepatol; 1999 Jan; 22(1):11-3. PubMed ID: 10089705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization and clinical impact of antinuclear antibodies in primary biliary cirrhosis.
    Muratori P; Muratori L; Ferrari R; Cassani F; Bianchi G; Lenzi M; Rodrigo L; Linares A; Fuentes D; Bianchi FB
    Am J Gastroenterol; 2003 Feb; 98(2):431-7. PubMed ID: 12591064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoimmune liver disease 2007.
    Muratori P; Granito A; Pappas G; Muratori L; Lenzi M; Bianchi FB
    Mol Aspects Med; 2008; 29(1-2):96-102. PubMed ID: 18067956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The antinuclear autoantibodies Sp100 and gp210 persist after orthotopic liver transplantation in patients with primary biliary cirrhosis.
    Luettig B; Boeker KH; Schoessler W; Will H; Loges S; Schmidt E; Worman HJ; Gershwin ME; Manns MP
    J Hepatol; 1998 May; 28(5):824-8. PubMed ID: 9625318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of two ELISA assays for anti-Sp100 determination.
    Manuel Lucena J; Montes Cano M; Luis Caro J; Respaldiza N; Alvarez A; Sánchez-Román J; Núñez-Roldán A; Wichmann I
    Ann N Y Acad Sci; 2007 Aug; 1109():203-11. PubMed ID: 17785307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Presence of SLA/LP autoantibodies in patients with primary biliary cirrhosis as a marker for secondary autoimmune hepatitis (overlap syndrome)].
    Kanzler S; Bozkurt S; Herkel J; Galle PR; Dienes HP; Lohse AW
    Dtsch Med Wochenschr; 2001 Apr; 126(16):450-6. PubMed ID: 11360449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 106.